Statement of Thailand to EB 126 (Jan 2010) on public health, innovation and intellectual property
The following statement was delivered by Thailand on Tuesday, 19 January 2010 during the discussion of agenda item 4.3 on public health, innovation and intellectual property. This statement requested Dr. Chan (Director-General, WHO) to conduct an investigation of the leaks of documents of the WHO Expert Working Group on R&D Financing to the IFPMA. In its statement, Thailand noted that the circle of trust had been broken.
I thank Madame DG to her explanation about the process and documentations including her constructive advices
Dec 9, 2009 Wikileaks documents related to the WHO EWG
On December 9, 2009, Wikileaks posted five sensitive documents related to the WHO Expert Working Group (EWG) on R&D Financing:
a non-public draft report of the WHO EWG a non-public Comparative Analysis done by the EWG the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) Overview of the EWG Comparative Analysis an IFPMA summary slide on the EWG Draft Report
Bolivian statement to EB 126 (Jan 2010) on public health, innovation and intellectual property
This is the statement that the Government of Bolivia delivered on January 19, 2010 at the 126th session of the WHO Executive Board public health, innovation and intellectual property including their views on the EWG process and the Executive Summary of the WHO Expert Working Group on R&D Financing.
The heart of Bolivia’s intervention is encapsulated in the penultimate paragraph of their intervention.
World Health Organization (WHO) to hold consultation on report of Expert Working Group on R&D financing
At the end of a dramatic debate that began yesterday, the Executive Board (EB) of the World Health Organization (WHO) agreed to hold a special consultation on the report of the WHO Expert Working Group (EWG) on R&D Financing. A face-to-face meeting will be held on May 13, a few days before the 63rd WHA begins on 17 May. There will also be opportunities for web submissions on the EWG report. In addition, Dr. Continue Reading
Brazilian statement to EB 126 (Jan 2010) on public health, innovation and intellectual property
On Monday, 18 January 2010, Brazil delivered the following statement to the 126th session of the Executive Board of the World Health Organization (WHO) under agenda item 4.3 “public health, innovation and intellectual property”. In her intervention, the delegate of Brazil stressed,
Corporate sponsors of the George Institute
As the 126th session of the Executive Board (EB) of the World Health Organization unfolds today, it appears that the EB will consider agenda item 4.3 on Public health, innovation and intellectual property: Global strategy and plan of action. Under scrutiny will be the work of the Expert Working Group on research and development financing which is mandated by resolution WHA61.21
Open Letter to the WHO EB from Cecilia López Montaño, EWG member
The following is a letter sent by Cecilia López Montaño, a member of the WHO Expert Working Group on R&D Financing to the WHO Executive Board:
Dear members of the Executive Board:
I am Cecilia López Montaño, senator of the Colombian Congress and member of the Expert Working Group on Research and Development Financing of the World Health Organization, in representation of the point of view of developing countries, I assume.
Final Report of the WHO Expert Working on R&D Financing published on Friday, January 15, 2010
At the proverbial 11th hour today, the World Health Organization published the final report of the “World Health Organization Expert Working Group on Research and Development Financing” in English three days before the commencement of the 126th session of the WHO Executive Board on January 18, 2010. At this juncture, it does not appear that the WHO Secretariat has made available official versions of this Report in Arabic, Chinese, French, Russian and Spanish for Member States’ consideration.
A closer look at the WHO EWG endorsed proposals on funding product development partnerships
The World Health Organization’s Expert Working Group on R&D Financing spent scant attention on how to raise money, but showed considerable interest in how to spend it. The clear favorite approach is to give grants to product development partnerships — the approach that has now become the most conventional approach, and one not surprisingly endorsed by the PDPs themselves, and also by the Gates Foundation and the IFPMA — two groups that are often seen as devoted to protecting the status quo in terms of intellectual property and business models for innovation.
The baffling WHO EWG analysis of innovation inducement prizes
The World Health Organization (WHO) Executive Board will soon consider the Executive Summary of the Report of the Expert Working Group on Research and Development Financing, a document, formally identified as EB 126/6 Add.1.
In the section of the report on “Funding allocation proposals,” the EWG considers two types of innovation inducement prizes, including
31 (c) milestone prizes; and
31 (d) end-prizes (cash)